Seroprevalence and Transmission of Human Influenza A(H5N1) Virus before and after Virus Reassortment, Cambodia, 2006–2014
Sowath Ly, Paul F. Horwood, Malen Chan, Sareth Rith, Sopheak Sorn, Kunthea Oeung, Kunthy Nguon, Siam Chan, Phalla Y, Amy Parry, Reiko Tsuyuoka, Sovann Ly, Beat Richner, Denis Laurent, Sirenda Vong, Philippe Dussart, Philippe Buchy, and Arnaud Tarantola
Author affiliations: Institut Pasteur du Cambodge, Phnom Penh, Cambodia (S. Ly, P. Horwood, M. Chan, P. Y, S. Rith, S. Sorn, K. Oeung K. Nguon, S. Chan, S. Vong, P. Dussart,, P. Buchy, A. Tarantola); World Health Organization, Phnom Penh (A. Parry, R. Tsuyuoka); Ministry of Health, Phnom Penh (S. Ly); Kantha Bopha Children's Hospitals, Siem Reap and Phnom Penh, Cambodia (B. Richner, D. Laurent); GSK Vaccines R&D, Singapore (P. Buchy)
Main Article
Figure
Figure. Geographic distribution of identified human cases in influenza A(H5N1)–affected villages, Cambodia, 2006–2014, Institut Pasteur du Cambodge, 2005–2014 (circles indicate areas investigated in 2014). Village distribution reflects population density. “Commune affected by A(H5N1)” refers to Cambodian communes in which A(H5N1) virus infection was laboratory-confirmed among humans or poultry.
Main Article
Page created: January 17, 2017
Page updated: January 17, 2017
Page reviewed: January 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.